A case of hyperammonemia occurring during treatment of metastatic renal cell carcinoma with axitinib

INTRODUCTION: Although the incidence of hyperammonemia as an adverse event of tyrosine kinase inhibitors is quite low, several cases of tyrosine kinase inhibitor associated hyperammonemia have been reported. We report a case of hyperammonemia, that occurred during combined treatment with axitinib an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Shoichi, Fujisaki, Yukiya, Onizuka, Chie, Hasuike, Satoru, Sato, Yuichiro, Mukai, Shoichiro, Kamoto, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315238/
https://www.ncbi.nlm.nih.gov/pubmed/37405030
http://dx.doi.org/10.1002/iju5.12586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315238/
https://www.ncbi.nlm.nih.gov/pubmed/37405030
http://dx.doi.org/10.1002/iju5.12586

Ejemplares similares